ABVC BIOPHARMA, INC. (ABVC) › Total AssetsABVC BIOPHARMA, INC. (ABVC) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $293.9K2011: $369.4K2012: $302.3K2013: $232.0K2014: $65.4K2015: $1.00M2016: $177.4K2017: $2.64M2018: $5.94M2019: $6.93M2020: $11.61M2021: $13.70M2022: $9.58M2023: $7.78M2024: $7.54M2025: $21.06M$21.06M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$21.06M+179.3%2024$7.54M-3.1%2023$7.78M-18.7%2022$9.58M-30.1%2021$13.70M+18.0%2020$11.61M+67.5%2019$6.93M+16.6%2018$5.94M+124.7%2017$2.64M+1390.4%2016$177.4K-82.3%2015$1.00M+1433.1%2014$65.4K-71.8%2013$232.0K-23.3%2012$302.3K-18.2%2011$369.4K+25.7%2010$293.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share